Key result
Hemodynamic status and regurgitant orifice area may explain outcome discrepancies in secondary MR edge-to-edge repair trials.
Why the study?
Differences in outcomes between two randomized trials of transcatheter edge-to-edge repair in secondary mitral regurgitation may relate to measures of regurgitant severity by echocardiography.
May guide hemodynamic stratification for TEER in secondary MR; leaves open prospective validation of EROA-adjusted selection.
Secondary mitral regurgitation (MR) is a hot topic of cardiovascular field after two randomised trials of transcatheter edge-to-edge repair in patients with secondary MR—Multicenter Study of Percutaneous Mitral Valve Repair MitraClip Device in Patients with Severe Secondary MR (MITRA-FR) and Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional MR (COAPT).1 2 The trials had similar aims, but in COAPT trial, MitraClip was associated with decreased risk of death and hospitalisation for heart failure, and in MITRA-FR, the intervention was not effectiveness for the prognosis. Many investigators try to clarify the difference between two trials.3 4 One possible explanation is the different cohort study between the two trials. From the standpoints of haemodynamic status, the effective regurgitant orifice area (EROA) can be estimated from left ventricular end-diastolic volume (LVEDV), left ventricular ejection fraction (LVEF) and regurgitant fraction (RF) based on the Gorlin hydraulic orifice equation. For example, in a patient with LVEDV of 230 mL, LVEF of 30% and RF of 50%, EROA can be estimated as around 0.3 cm2. If the actual EROA is over the estimated EROA from LVEDV, LVEF and RF, this haemodynamic status …
No takes yet. Share an insight, caveat, or question.
Kenya Kusunose (2020) conducted an editorial in Secondary mitral regurgitation. Transcatheter edge-to-edge repair (MitraClip) was evaluated. The discrepancy in outcomes between transcatheter edge-to-edge repair trials for secondary mitral regurgitation may be explained by differences in cohort hemodynamic status and effective regurgitant orifice area.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: